메뉴 건너뛰기




Volumn 57, Issue 4, 2011, Pages 335-338

Incidence of fluoroquinolone-resistant and extended-spectrum β-lactamase-producing escherichia coli at a comprehensive cancer center in the United States

Author keywords

Escherichia coli; Extended spectrum lactamase; Fluoroquinolones; Resistance

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; MEROPENEM; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

EID: 80052568402     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000329661     Document Type: Article
Times cited : (37)

References (11)
  • 1
    • 0032777982 scopus 로고    scopus 로고
    • Pseudomonas aeruginosa - Still a frequent pathogen in patients with cancer: 11-year experience at a comprehensive cancer center
    • Rolston KV, Tarrand JJ: Pseudomonas aeruginosa-still a frequent pathogen in patients with cancer: 11-year experience at a comprehensive cancer center. Clin Infect Dis 1999; 29: 463-464. (Pubitemid 29380232)
    • (1999) Clinical Infectious Diseases , vol.29 , Issue.2 , pp. 463-464
    • Rolston, K.V.I.1    Tarrand, J.J.2
  • 3
    • 4344700150 scopus 로고    scopus 로고
    • Predicting hospital rates of fluoroquinolone-resistant Pseudomonas aeruginosa from fluoroquinolone use in us hospitals and their surrounding communities
    • DOI 10.1086/422647
    • Polk RE, Johnson CK, McClish D, Wenzel RP, Edmond MB: Predicting hospital rates of fluoroquinolone-resistant Pseudomonas aeruginosa from fluoroquinolone use in US hospitals and their surrounding communities. Clin Infect Dis 2004; 39: 497-503. (Pubitemid 39120924)
    • (2004) Clinical Infectious Diseases , vol.39 , Issue.4 , pp. 497-503
    • Polk, R.E.1    Johnson, C.K.2    McClish, D.3    Wenzel, R.P.4    Edmond, M.B.5
  • 4
    • 40049109979 scopus 로고    scopus 로고
    • Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: Results of a prospective study on 823 patients at a single institution
    • DOI 10.1093/jac/dkm514
    • Cattaneo C, Quaresmini G, Casari S, Capucci MA, Micheletti M, Borlenghi E, Signorini L, Re A,Carosi G, Rossi G: Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution. J Antimicrob Chemother 2008; 61: 721-728. (Pubitemid 351321152)
    • (2008) Journal of Antimicrobial Chemotherapy , vol.61 , Issue.3 , pp. 721-728
    • Cattaneo, C.1    Quaresmini, G.2    Casari, S.3    Capucci, M.A.4    Micheletti, M.5    Borlenghi, E.6    Signorini, L.7    Re, A.8    Carosi, G.9    Rossi, G.10
  • 5
    • 78449234976 scopus 로고    scopus 로고
    • Emerging resistant Gram-negative aerobic bacilli in hospital-acquired infections
    • Kunz AN, Brook I: Emerging resistant Gram-negative aerobic bacilli in hospital-acquired infections. Chemotherapy 2010; 56: 492-500.
    • (2010) Chemotherapy , vol.56 , pp. 492-500
    • Kunz, A.N.1    Brook, I.2
  • 7
    • 0032822405 scopus 로고    scopus 로고
    • Susceptibility surveillance among gram-negative bacilli at a cancer center
    • DOI 10.1159/000007223
    • Jacobson K, Rolston K, Elting L, LeBlanc B, Whimbey E, Ho DH: Susceptibility surveillance among Gram-negative bacilli at a cancer center. Chemotherapy 1999; 45: 325-334. (Pubitemid 29410811)
    • (1999) Chemotherapy , vol.45 , Issue.5 , pp. 325-334
    • Jacobson, K.1    Rolston, K.2    Elting, L.3    LeBlanc, B.4    Whimbey, E.5    Ho, D.H.6
  • 8
    • 76249105326 scopus 로고    scopus 로고
    • Perils of quinolone exposure in cancer patients: Breakthrough bacteremia with multidrug-resistant organisms
    • Rangaraj G, Granwehr BP, Jiang Y, Hachem R, Raad I: Perils of quinolone exposure in cancer patients: breakthrough bacteremia with multidrug-resistant organisms. Cancer 2010; 116: 967-973.
    • (2010) Cancer , vol.116 , pp. 967-973
    • Rangaraj, G.1    Granwehr, B.P.2    Jiang, Y.3    Hachem, R.4    Raad, I.5
  • 10
    • 66749135850 scopus 로고    scopus 로고
    • Prevalence and antimicrobial resistance patterns of extended-spectrum- lactamaseproducing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul university hospital
    • Koksal F, Ak K, Kucukbasmaci O, Samasti M: Prevalence and antimicrobial resistance patterns of extended-spectrum-lactamaseproducing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul university hospital. Chemotherapy 2009; 55: 293-297.
    • (2009) Chemotherapy , vol.55 , pp. 293-297
    • Koksal, F.1    Ak, K.2    Kucukbasmaci, O.3    Samasti, M.4
  • 11
    • 0038707628 scopus 로고    scopus 로고
    • Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States
    • DOI 10.1086/374339
    • Wisplinghoff H, Seifert H, Wenzel R, Edmond MB: Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States . Clin Infect Dis 2003; 36: 1103-1110. (Pubitemid 36553108)
    • (2003) Clinical Infectious Diseases , vol.36 , Issue.9 , pp. 1103-1110
    • Wisplinghoff, H.1    Seifert, H.2    Wenzel, R.P.3    Edmond, M.B.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.